Xtant Medical Holdings, Inc. SEC filings XTNT

Xtant Medical Holdings, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 1, 2011. Its latest annual report, Form ARS, was filed on Jun 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Xtant Medical Holdings, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Shareholder vote results
Aug 7, 2026 Aug 7, 2026
ARS Annual report to shareholders Jun 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 23, 2026 —
DEF 14A Proxy statement Jun 23, 2026 Jun 23, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 13, 2026 May 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 13, 2026 Apr 10, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Other events
Mar 2, 2026 Mar 2, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Jan 16, 2026 Jan 15, 2026
8-K Current report
Other events
Jan 16, 2026 Jan 15, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Dec 3, 2025 Dec 1, 2025
4/A Primary document Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
4 Insider transaction Nov 18, 2025 Nov 15, 2025
S-8 Employee stock plan registration Nov 10, 2025 —
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Officer or director change, Shareholder vote results
Nov 10, 2025 Nov 7, 2025
ARS Annual report to shareholders Sep 15, 2025 Dec 31, 2024
DEFA14A Additional proxy material Sep 15, 2025 —
DEF 14A Proxy statement Sep 15, 2025 Sep 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
3 Initial insider ownership Aug 8, 2025 Aug 1, 2025
8-K Current report
Other events
Aug 8, 2025 Aug 8, 2025
3 Initial insider ownership Aug 8, 2025 Aug 1, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 5, 2025 —
8-K Current report
Officer or director change
Aug 4, 2025 Aug 1, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jul 8, 2025 Jul 7, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
424B3 Prospectus May 20, 2025 —
EFFECT Filing May 19, 2025 —
CORRESP Letter to the SEC May 15, 2025 —
UPLOAD Letter from the SEC May 15, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
S-1 Registration statement May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
SCHEDULE 13D Ownership over 5% (active) Apr 17, 2025 —
3 Initial insider ownership Apr 17, 2025 Apr 10, 2025
8-K Current report
Agreement ended, Results of operations, Change in control, Regulation FD disclosure, Other events
Apr 16, 2025 Apr 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 16, 2025 —
4 Insider transaction Apr 14, 2025 Apr 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 14, 2025 —
8-K Current report
Material agreement
Apr 11, 2025 Apr 10, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
4/A Primary document Jan 17, 2025 Apr 3, 2024
4 Insider transaction Jan 17, 2025 Jan 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
4 Insider transaction Oct 16, 2024 Oct 15, 2024
EFFECT Filing Sep 11, 2024 —
424B3 Prospectus Sep 11, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 10, 2024 —
EFFECT Filing Sep 9, 2024 —
CORRESP Letter to the SEC Sep 9, 2024 —
UPLOAD Letter from the SEC Sep 9, 2024 —
POS AM Filing Sep 4, 2024 —
S-3 Shelf registration Sep 3, 2024 —
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
D Filing Aug 12, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 8, 2024 Aug 7, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jul 24, 2024 Jul 23, 2024
ARS Annual report to shareholders Jun 10, 2024 Dec 31, 2023
DEF 14A Proxy statement Jun 10, 2024 Jun 10, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
EFFECT Filing Apr 8, 2024 —
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
CORRESP Letter to the SEC Apr 4, 2024 —
UPLOAD Letter from the SEC Apr 2, 2024 —
S-3 Shelf registration Apr 1, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Mar 7, 2024 Mar 7, 2024
4/A Primary document Feb 16, 2024 Oct 15, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Jan 18, 2024 Jan 16, 2024
4 Insider transaction Nov 17, 2023 Nov 17, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K/A Amended current report Oct 26, 2023 Aug 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2023 Oct 23, 2023
4 Insider transaction Oct 17, 2023 Oct 15, 2023
8-K Current report
Auditor change
Aug 18, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 17, 2023 Aug 15, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Aug 10, 2023 Aug 10, 2023
8-K Current report
Other events
Aug 9, 2023 Aug 8, 2023
SC 13D/A Amended ownership over 5% (active) Aug 3, 2023 —
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 1, 2023 Aug 1, 2023
S-8 Employee stock plan registration Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
8-K Current report
Regulation FD disclosure
Jul 28, 2023 Jul 28, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jul 28, 2023 Jul 26, 2023
424B3 Prospectus Jul 14, 2023 —
EFFECT Filing Jul 13, 2023 —
D Filing Jul 12, 2023 —
CORRESP Letter to the SEC Jul 11, 2023 —
S-3/A Filing Jul 11, 2023 —
8-K Current report
Material agreement
Jul 11, 2023 Jul 10, 2023
UPLOAD Letter from the SEC Jul 10, 2023 —
S-3 Shelf registration Jul 7, 2023 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Jul 3, 2023 Jul 3, 2023
8-K Current report
Material agreement
Jun 20, 2023 Jun 18, 2023
4 Insider transaction Jun 15, 2023 Jun 15, 2023
ARS Annual report to shareholders Jun 8, 2023 Dec 31, 2022
DEF 14A Proxy statement Jun 8, 2023 Jun 7, 2023
3 Initial insider ownership May 22, 2023 May 16, 2023
PRE 14A Preliminary proxy statement May 19, 2023 May 19, 2023
8-K Current report
Bylaw or fiscal year change
May 19, 2023 May 16, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
May 18, 2023 May 16, 2023
4 Insider transaction May 16, 2023 May 15, 2023
8-K/A Amended current report May 16, 2023 Feb 28, 2023
SC 13D/A Amended ownership over 5% (active) May 5, 2023 —
3 Initial insider ownership May 4, 2023 May 1, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Officer or director change
May 4, 2023 May 1, 2023
10-K Annual report Mar 7, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
Mar 1, 2023 Feb 28, 2023
4 Insider transaction Feb 17, 2023 Feb 15, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
8-K Current report
Other events
Feb 1, 2023 Feb 1, 2023
4 Insider transaction Jan 19, 2023 Jan 18, 2023
3 Initial insider ownership Jan 18, 2023 Jan 16, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
4 Insider transaction Nov 17, 2022 Nov 15, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
XTNT (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Belgrade, MT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1453593
Former names
Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.